NASDAQ:ARDS

Aridis Pharmaceuticals, Inc.

Stock

USD

Market Cap

2.94M

Beta: 0.99

Volume Today

174.90K

Avg: 997.59K

PE Ratio

−4.42

PFCF: −0.20

Overview Analysis Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22
net income	-8.42M -	-24.66M 192.76%	-22.11M 10.35%	-29.68M 34.27%	-22.33M 24.76%	-42.19M 88.93%	-30.37M 28.02%
depreciation and amortization	23K -	62K 169.57%	283K 356.45%	338K 19.43%	337K 0.30%	435K 29.08%	487K 11.95%
deferred income tax	172K -					-722K -
stock based compensation	858K -	1.61M 87.41%	1.66M 3.11%	2.01M 21.23%	2.13M 5.87%	2.25M 5.78%	1.48M 34.30%
change in working capital	909K -	277K 69.53%	-2.52M 1,007.94%	18.22M 824.57%	-617K 103.39%	10.52M 1,804.54%	-1.30M 112.35%
accounts receivables	454K -	67K 85.24%	-1.66M 2,577.61%	1.66M 200%			-1M -
inventory	-44K -	-341K 675%	-2.85M 737.24%	-2.55M 10.75%
accounts payables	319K -	431K 35.11%	2.10M 386.54%	-469K 122.37%	-83K 82.30%	2.65M 3,297.59%	-2.93M 210.47%
other working capital	180K -	120K 33.33%	-97K 180.83%	19.58M 20,285.57%	-534K 102.73%	7.86M 1,572.47%	2.63M 66.51%
other non cash items	369K -	5.15M 1,296.21%	-1.59M 130.90%	951K 159.74%	9K 99.05%	6.78M 75,188.89%	577K 91.48%
net cash provided by operating activities	-6.09M -	-17.56M 188.24%	-24.27M 38.24%	-8.16M 66.38%	-20.48M 150.96%	-22.94M 12.01%	-29.13M 26.99%
investments in property plant and equipment	-15K -	-698K 4,553.33%	-677K 3.01%	-174K 74.30%	-367K 110.92%	-530K 44.41%	-82K 84.53%
acquisitions net			-1M -
purchases of investments			-1M -
sales maturities of investments
other investing activites			1M -
net cash used for investing activites	-15K -	-698K 4,553.33%	-1.68M 140.26%	-174K 89.62%	-367K 110.92%	-530K 44.41%	-82K 84.53%
debt repayment	-300K -						-1.80M -
common stock issued			25.08M -	4.96M 80.23%	7.95M 60.33%	29.71M 273.82%	12.61M 57.57%
common stock repurchased
dividends paid			-1.36M -			-4.13M -
other financing activites	25.80M -	21.06M 18.39%	1.37M 93.51%	35K 97.44%	729K 1,982.86%	9.13M 1,152.67%	3.97M 56.49%
net cash used provided by financing activities	25.50M -	21.06M 17.43%	25.09M 19.13%	4.99M 80.10%	8.68M 73.80%	34.72M 300.09%	14.78M 57.43%
effect of forex changes on cash
net change in cash	19.40M -	2.81M 85.54%	-859K 130.62%	-3.34M 288.82%	-12.16M 264.22%	11.25M 192.51%	-14.43M 228.19%
cash at beginning of period	2.89M -	22.29M 670.78%	25.10M 12.58%	24.24M 3.42%	20.90M 13.78%	8.73M 58.21%	19.99M 128.88%
cash at end of period	22.29M -	25.10M 12.58%	24.24M 3.42%	20.90M 13.78%	8.73M 58.21%	19.99M 128.88%	5.56M 72.19%
operating cash flow	-6.09M -	-17.56M 188.24%	-24.27M 38.24%	-8.16M 66.38%	-20.48M 150.96%	-22.94M 12.01%	-29.13M 26.99%
capital expenditure	-15K -	-698K 4,553.33%	-677K 3.01%	-174K 74.30%	-367K 110.92%	-530K 44.41%	-82K 84.53%
free cash flow	-6.11M -	-18.25M 198.97%	-24.95M 36.66%	-8.33M 66.60%	-20.84M 150.13%	-23.47M 12.58%	-29.21M 24.47%

All numbers in USD (except ratios and percentages)